Compare · AIRJ vs TMO
AIRJ vs TMO
Side-by-side comparison of AirJoule Technologies Corporation (AIRJ) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AIRJ and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $174.52B, about 549.3x AIRJ ($317.7M).
- Over the past year, AIRJ is up 3.9% and TMO is up 14.9% - TMO leads by 11.0 points.
- TMO has been more active in the news (17 items in the past 4 weeks vs 10 for AIRJ).
- TMO has more recent analyst coverage (25 ratings vs 5 for AIRJ).
- Company
- AirJoule Technologies Corporation
- Thermo Fisher Scientific Inc
- Price
- $4.64-4.72%
- $469.56-0.67%
- Market cap
- $317.7M
- $174.52B
- 1M return
- +32.95%
- -1.03%
- 1Y return
- +3.92%
- +14.92%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 10
- 17
- Recent ratings
- 5
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest AIRJ
- SEC Form POS AM filed by AirJoule Technologies Corporation
- SEC Form POS AM filed by AirJoule Technologies Corporation
- Director Murphy Thomas Edward converted options into 25,487 shares, increasing direct ownership by 80% to 57,437 units (SEC Form 4)
- Director Sterling Denise Marie Brucia converted options into 25,487 shares (SEC Form 4)
- Director Porter Stuart D converted options into 28,037 shares, increasing direct ownership by 4% to 804,916 units (SEC Form 4)
- Director Agrawal Ajay converted options into 28,037 shares, increasing direct ownership by 519% to 33,437 units (SEC Form 4)
- Director Zaatari Marwa converted options into 28,037 shares, increasing direct ownership by 519% to 33,437 units (SEC Form 4)
- AirJoule Technologies Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 424B5 filed by AirJoule Technologies Corporation
- AirJoule Technologies Announces $15.0 Million Registered Direct Offering of Common Stock
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)